These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 18433342)

  • 1. The role of hepatic transporters in drug elimination.
    Funk C
    Expert Opin Drug Metab Toxicol; 2008 Apr; 4(4):363-79. PubMed ID: 18433342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of Hepatic Transporters in Clinical Disposition of Drugs and Their Metabolites.
    Patel M; Taskar KS; Zamek-Gliszczynski MJ
    J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S23-39. PubMed ID: 27385177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug transport proteins in the liver.
    Faber KN; Müller M; Jansen PL
    Adv Drug Deliv Rev; 2003 Jan; 55(1):107-24. PubMed ID: 12535576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Sinusoidal Drug Uptake Transporter Activities in Primary Human Hepatocytes.
    Le Vée M; Jouan E; Denizot C; Parmentier Y; Fardel O
    Methods Mol Biol; 2015; 1250():287-302. PubMed ID: 26272151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Hepatic Drug Transporters in Drug Development.
    Liu H; Sahi J
    J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S11-22. PubMed ID: 27385168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescence-based methods for studying activity and drug-drug interactions of hepatic solute carrier and ATP binding cassette proteins involved in ADME-Tox.
    Özvegy-Laczka C; Ungvári O; Bakos É
    Biochem Pharmacol; 2023 Mar; 209():115448. PubMed ID: 36758706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drugs and hepatic transporters: A review.
    Jetter A; Kullak-Ublick GA
    Pharmacol Res; 2020 Apr; 154():104234. PubMed ID: 31004787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of hepatic uptake transporters on pharmacokinetics and drug-drug interactions: use of assays and models for decision making in the pharmaceutical industry.
    Soars MG; Webborn PJ; Riley RJ
    Mol Pharm; 2009; 6(6):1662-77. PubMed ID: 19402709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of Transporter Polymorphisms on Drug Disposition and Response: A Perspective From the International Transporter Consortium.
    Yee SW; Brackman DJ; Ennis EA; Sugiyama Y; Kamdem LK; Blanchard R; Galetin A; Zhang L; Giacomini KM
    Clin Pharmacol Ther; 2018 Nov; 104(5):803-817. PubMed ID: 29679469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Drug Transporters on Pharmacological Responses and Safety.
    Liu CX; Yi XL; Fan HR; Wu WD; Zhang X; Xiao XF; He X
    Curr Drug Metab; 2015; 16(9):732-52. PubMed ID: 26630905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of human hepatic drug transporter activity and expression by cigarette smoke condensate.
    Sayyed K; Vee ML; Abdel-Razzak Z; Jouan E; Stieger B; Denizot C; Parmentier Y; Fardel O
    Toxicology; 2016 Jul; 363-364():58-71. PubMed ID: 27450509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer resistance protein (ABCG2) in clinical pharmacokinetics and drug interactions: practical recommendations for clinical victim and perpetrator drug-drug interaction study design.
    Lee CA; O'Connor MA; Ritchie TK; Galetin A; Cook JA; Ragueneau-Majlessi I; Ellens H; Feng B; Taub ME; Paine MF; Polli JW; Ware JA; Zamek-Gliszczynski MJ
    Drug Metab Dispos; 2015 Apr; 43(4):490-509. PubMed ID: 25587128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro-in vivo extrapolation of transporter-mediated clearance in the liver and kidney.
    Kusuhara H; Sugiyama Y
    Drug Metab Pharmacokinet; 2009; 24(1):37-52. PubMed ID: 19252335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organic Anion Transporter 2-Mediated Hepatic Uptake Contributes to the Clearance of High-Permeability-Low-Molecular-Weight Acid and Zwitterion Drugs: Evaluation Using 25 Drugs.
    Kimoto E; Mathialagan S; Tylaska L; Niosi M; Lin J; Carlo AA; Tess DA; Varma MVS
    J Pharmacol Exp Ther; 2018 Nov; 367(2):322-334. PubMed ID: 30135178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of Model-Based Approaches to Evaluate Hepatic Transporter-Mediated Drug Clearance: In vitro, In vivo, and In vitro-In vivo Extrapolation.
    Liu Z; Liu K
    Curr Drug Metab; 2016; 17(5):456-68. PubMed ID: 26750112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transporter-Enzyme Interplay: Deconvoluting Effects of Hepatic Transporters and Enzymes on Drug Disposition Using Static and Dynamic Mechanistic Models.
    Varma MV; El-Kattan AF
    J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S99-S109. PubMed ID: 27385183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Animal models and intestinal drug transport.
    Glaeser H; Fromm MF
    Expert Opin Drug Metab Toxicol; 2008 Apr; 4(4):347-61. PubMed ID: 18433341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of Drug or Food with Drug Transporters in Intestine and Liver.
    Nakanishi T; Tamai I
    Curr Drug Metab; 2015; 16(9):753-64. PubMed ID: 26630906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Modeling of Drug-Transporter Interactions-An International Transporter Consortium Perspective.
    Schlessinger A; Welch MA; van Vlijmen H; Korzekwa K; Swaan PW; Matsson P
    Clin Pharmacol Ther; 2018 Nov; 104(5):818-835. PubMed ID: 29981151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β2-adrenergic receptor-mediated in vitro regulation of human hepatic drug transporter expression by epinephrine.
    Mayati A; Moreau A; Denizot C; Stieger B; Parmentier Y; Fardel O
    Eur J Pharm Sci; 2017 Aug; 106():302-312. PubMed ID: 28603032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.